Entrada Therapeutics
TRDA
#9077
Rank
A$0.25 B
Marketcap
A$6.57
Share price
-6.25%
Change (1 day)
-58.02%
Change (1 year)

EPS for Entrada Therapeutics (TRDA)

EPS in 2026 (TTM): A-$5.59

According to Entrada Therapeutics's latest financial reports the company's current EPS (TTM) is A-$5.80. In 2025 the company made an earnings per share (EPS) of A-$5.23 a decrease over its 2024 EPS that were of A$3.01.

EPS history for Entrada Therapeutics from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$5.596.95%
2025A-$5.23-273.87%
2024A$3.01
2022A-$4.5631.74%
2021A-$3.46